FeedingTrends
Hormonal Therapy Market Size, Share, Analysis Report by 2026
a year ago
3 min read

Hormonal Therapy Market Size, Share, Analysis Report by 2026

Rise in incidence and prevalence of cancer such as breast cancer and prostate cancer is projected to catalyze the hormonal therapy market. Also, the escalating in demand for newer agents which aim to avoid resistance and combination therapies is leading to boost the growth of hormonal therapy market. Moreover, the rise in government and private organization support to improve the awareness about cancer treatment is anticipated to accelerate the market. For example, the World Health Organization promotes breast cancer regulate within the circumstance of comprehensive national cancer control programs. In addition to this, in spite of high cost involved in research and development, pharmaceutical companies are showing high interest in this field. This is likely to propel growth of the hormonal therapy market.

The global Hormonal Therapy market is segregated on the basis of Type as Anti-estrogens, Aromatase Inhibitors, Anti-androgens, Gonadotropin Releasing Hormone (GnRH) and Others. Based on Application the global Hormonal Therapy market is segmented in Breast Cancer, Prostate Cancer, Ovarian Cancer and Others. Based on Route of Administration the global Hormonal Therapy market is segmented in Oral, Subcutaneous and Intramuscular.

The global Hormonal Therapy market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Hormonal Therapy market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Browse Full Report from Here: https://www.marketresearchengine.com/hormonal-therapy-market

Competitive Rivalry

AstraZeneca, Novartis, Pfizer, Sanofi, Takeda, Roche, Amgen, Samyang Biopharmaceuticals, Tolmar, Bluebird Bio, Bristol-Myers Squibb, Exelixis, Guardant Health, Illumina, and others are among the major players in the global Hormonal Therapy market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Hormonal Therapy Market has been segmented as below:

Hormonal Therapy Market, By Type

  • Anti-estrogens

  • Aromatase Inhibitors

  • Anti-androgens

  • Gonadotropin Releasing Hormone (GnRH)

  • Others

Hormonal Therapy Market, By Application

  • Breast Cancer

  • Prostate Cancer

  • Ovarian Cancer

  • Others

Hormonal Therapy Market, By Route of Administration

  • Oral

  • Subcutaneous

  • Intramuscular

Hormonal Therapy Market, By Region

  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World

Hormonal Therapy Market, By Company

  • AstraZeneca

  • Novartis

  • Pfizer

  • Sanofi

  • Takeda

  • Roche

  • Amgen

  • Samyang Biopharmaceuticals

  • Tolmar

  • Bluebird Bio

  • Bristol-Myers Squibb

  • Exelixis

  • Guardant Health

  • Illumina

The report covers:

  • Global Hormonal Therapy market sizes from 2021 to 2028, along with CAGR for 2023-2028

  • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028

  • Global Hormonal Therapy market trends, covering comprehensive range of consumer trends & manufacturer trends

  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Hormonal Therapy market

  • Major market opportunities and challenges in forecast timeframe to be focused

  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management

  • Comprehensive company profiles of the key industry players

Request Sample Report from here:

https://www.marketresearchengine.com/hormonal-therapy-market

Report Scope:

The global Hormonal Therapy market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Hormonal Therapy market share. Major industry players with significant revenue share include AstraZeneca, Novartis, Pfizer, Sanofi, Takeda, Roche, Amgen, Samyang Biopharmaceuticals, Tolmar, Bluebird Bio, Bristol-Myers Squibb, Exelixis, Guardant Health, Illumina, and others.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com

Appreciate the creator